Health Partners Neuroscience Center Research and Innovation – FDA Inspection, Mar 21, 2025

Record Details

This FDA Inspection record concerns Health Partners Neuroscience Center Research and Innovation, with an inspection on March 21, 2025, issued by the Minneapolis District Office, covering human drugs.

Company: Health Partners Neuroscience Center Research and Innovation
Inspection Date: March 21, 2025
Product Type: Human Drugs
Office: Minneapolis District Office
People: Hugh M. McClure III (Issuing Officer)
Mark J. Seaton (Company Rep)
Zhou Chen (Company Rep)

View Company Profile

ID · b7529b5a-0a43-491f-8197-26da6fc6dad0

Inspection Facts

Inspection number: 1264409
FDA center: Human Drugs
Project area: Bioresearch Monitoring: Human Drugs
Outcome: Form 483 issued, view the record

FDA Citations

21 CFR 58.113(a)(1)Mixtures: uniformity and concentration
21 CFR 58.185(c)Final report: corrections or additions
21 CFR 58.190(a)Archives: data, documentation, specimens
21 CFR 58.35(b)(6)QAU: review final study report
21 CFR 58.81(b)SOPs: required
21 CFR 58.90(g)Animal care: analysis of feed and water

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Health Partners Neuroscience Center Research and Innovation

FDA Inspection

Health Partners Neuroscience Center Research and InnovationMarch 21, 2025